H3B-8800 (RVT-2001)
Showing 1 - 25 of 7,659
Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- H3B-8800 (RVT-2001)
-
Stanford, California
- +26 more
Mar 23, 2022
Graves' Ophthalmopathy (GO) Trial in Worldwide (RVT-1401 (Administered via subcutaneous injection), Placebo (Administered via
Terminated
- Graves' Ophthalmopathy (GO)
- RVT-1401 (Administered via subcutaneous injection)
- Placebo (Administered via subcutaneous injection)
-
Beverly Hills, California
- +24 more
Aug 26, 2022
Lymphoma Trial in Worldwide (bleomycin sulfate, filgrastim, pegfilgrastim)
Completed
- Lymphoma
- bleomycin sulfate
- +12 more
-
Garran, Australian Capital Territory, Australia
- +139 more
Dec 19, 2022
Relapsed DLBCL, Refractory DLBCL Trial in Worldwide (Loncastuximab Tesirine, Rituximab, Gemcitabine)
Recruiting
- Relapsed Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Loncastuximab Tesirine
- +3 more
-
La Jolla, California
- +59 more
Aug 4, 2022
Prevention & Control Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Aspirin, Aspirin )
Completed
- Prevention & Control
- Rivaroxaban (Xarelto, BAY59-7939)
- +5 more
-
Birmingham, Alabama
- +564 more
Nov 3, 2022
Graves' Ophthalmopathy Trial in Canada (RVT-1401)
Completed
- Graves' Ophthalmopathy
-
Vancouver, British Columbia, Canada
- +3 more
Dec 24, 2021
Prurigo Nodularis, Pruritis Trial in Worldwide (vixarelimab, Placebo)
Active, not recruiting
- Prurigo Nodularis
- Pruritis
- vixarelimab
- Placebo
-
Anniston, Alabama
- +76 more
Jan 3, 2023
Advanced or Metastatic NSCLC Trial (Ceralasertib, Durvalumab, Docetaxel)
Recruiting
- Advanced or Metastatic Non-Small Cell Lung Cancer
- Ceralasertib
- +2 more
-
Chandler, Arizona
- +80 more
Jan 12, 2023
Paroxysmal Supraventricular Tachycardia Trial in Worldwide (Etripamil NS)
Active, not recruiting
- Paroxysmal Supraventricular Tachycardia
- Etripamil NS
-
Gilbert, Arizona
- +123 more
Nov 21, 2022
Advanced Hepatocellular Carcinoma, Hepatocellular Carcinoma, Liver Cancer Trial in Worldwide (H3B-6527)
Completed
- Advanced Hepatocellular Carcinoma
- +5 more
-
Los Angeles, California
- +43 more
Apr 5, 2022
Hyperkalemia Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), SZC Placebo)
Recruiting
- Hyperkalemia
- Sodium Zirconium Cyclosilicate (SZC)
- SZC Placebo
-
Huntsville, Alabama
- +355 more
Feb 1, 2023
Carcinoma, Non-Small-Cell Lung Trial in Worldwide (Savolitinib, Osimertinib, Pemetrexed)
Not yet recruiting
- Carcinoma
- Non-Small-Cell Lung
- Savolitinib
- +4 more
-
Orange City, Florida
- +78 more
Jul 20, 2022
Pneumococcal Infections Trial in Worldwide (V114, Prevnar 13™, PNEUMOVAX™23)
Completed
- Pneumococcal Infections
- V114
- +2 more
-
Palo Alto, California
- +51 more
Sep 23, 2022
Hypercholesterolemia Trial in Worldwide (ALIROCUMAB SAR236553 (REGN727), (for injection training only), ezetimibe)
Completed
- Hypercholesterolemia
- ALIROCUMAB SAR236553 (REGN727)
- +5 more
-
Graz, Austria
- +152 more
Mar 21, 2022
Heart Failure, Chronic Kidney Disease Trial in Worldwide (AZD9977, Dapagliflozin)
Recruiting
- Heart Failure
- Chronic Kidney Disease
-
Hot Springs National Park, Arkansas
- +279 more
Feb 1, 2023
Intensive Lifestyle Intervention on Employment, Earnings, and
Active, not recruiting
- Diabetes Mellitus, Type 2
- Intensive lifestyle intervention (ILI)
- Diabetes support and education (DSE)
- (no location specified)
Sep 29, 2022
Severe Hypertriglyceridemia Trial in Worldwide (ARO-APOC3, Placebo)
Active, not recruiting
- Severe Hypertriglyceridemia
- ARO-APOC3
- Placebo
-
Beverly Hills, California
- +72 more
Nov 29, 2022
Modified Release Oral Formulation, Left Ventricular Systolic Dysfunction, Chronic Heart Failure Trial in Worldwide (Omecamtiv
Completed
- Modified Release Oral Formulation
- +6 more
- Omecamtiv Mecarbil Matrix F1 Formulation
- +3 more
-
Mobile, Alabama
- +100 more
Jul 25, 2021
COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Tozorakimab
- Placebo
-
Mobile, Alabama
- +199 more
Aug 10, 2022
From Lung and Blood Samples in Suspected Lung Cancer
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Bronchoscopic Biopsy
- Blood Sample
-
Farmington, Connecticut
- +4 more
Aug 17, 2022
Atrial Fibrillation (AF) Trial in Worldwide (BAY2433334, Apixaban, BAY2433334 matching )
Completed
- Atrial Fibrillation (AF)
- BAY2433334
- +3 more
-
Braunau, Oberösterreich, Austria
- +92 more
Oct 12, 2021